Valens Semiconductor Ltd.·4

Jun 16, 11:21 AM ET

Chairman David 4

4 · Valens Semiconductor Ltd. · Filed Jun 16, 2026

Research Summary

AI-generated summary of this filing

Updated

Valens (VLN) SVP David Exercises Options, Sells 4,000 Shares

What Happened
David, SVP, R&D at Valens Semiconductor Ltd., exercised stock options and sold shares on June 15, 2026. The filing shows two option exercises (4,000 shares @ $0.86 for $3,440; and 4,000 shares reported at $0.00) and an open‑market sale of 4,000 shares at a weighted average price of $2.43 for gross proceeds of $9,730. The transactions were reported on Form 4 filed the next day.

Key Details

  • Transaction date: 2026-06-15 (Form 4 filed 2026-06-16 — timely).
  • Exercises: 4,000 shares @ $0.86 (cost $3,440) + 4,000 shares reported at $0.00 (both listed as option exercises).
  • Sale: 4,000 shares sold @ $2.43 (weighted avg) for $9,730 gross proceeds.
  • Shares owned after transaction: not reported in the provided filing details.
  • Notable footnotes: transactions were executed under a Rule 10b5‑1 trading plan (adopted Aug 16, 2024); the shares were acquired upon exercise of stock options and some shares sold were those newly exercised; the $2.43 is a weighted average price and full per‑lot detail is available upon request.

Context
The pattern—exercise of options and immediate sale of some shares the same day—is consistent with a cashless exercise where exercised shares are sold to cover costs/taxes. The $0.00 line likely reflects shares used to satisfy exercise price or tax withholding rather than a market sale. The filing notes the sale was made pursuant to a prearranged 10b5‑1 plan, which can explain scheduled sales and reduces the informational value of the sale as a standalone signal of insider sentiment.

Insider Transaction Report

Form 4
Period: 2026-06-15
Transactions
  • Exercise/Conversion

    Ordinary Shares

    [F2]
    2026-06-15$0.86/sh+4,000$3,440407,968 total
  • Sale

    Ordinary Shares

    [F1][F3][F4]
    2026-06-15$2.43/sh4,000$9,730403,968 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F5]
    2026-06-154,00075,695 total
    Exercise: $0.86From: 2022-06-01Exp: 2031-06-09Ordinary Shares (4,000 underlying)
Footnotes (5)
  • [F1]The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024
  • [F2]The shares were acquired upon the exercise of stock options
  • [F3]The shares sold were acquired upon the exercise of stock options on the same date
  • [F4]The price reported is a weighted average price. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request.
  • [F5]The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.
Signature
/s/ Yohanan Azriel on behalf of Oppenheimer Israel, as Attorney-in-fact|2026-06-16

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT